[Indications for anticoagulant use in secondary prevention of strokes]

Presse Med. 2003 Jul 26;32(25):1175-80.
[Article in French]

Abstract

THE CONTEXT: The demonstration of the efficacy of oral anticoagulants in the secondary prevention of ischemic stroke represents a major progress in medicine in the last twenty years. Efficacy in fact depends on the causes and this determines the indications. ADMITTED AND DEMONSTRATED INDICATIONS: Cardiac arrhythmia due to atrial fibrillation and the existence of mechanical prosthetic valves are the only two indications that have been demonstrated with sufficient proof. ADMITTED NON-DEMONSTRATED INDICATIONS: These are basically the dissection of cervical arteries, aortal cross atheroma, vascular cerebral accidents within the context of antiphospholipid antibody syndromes. POSSIBLE INDICATIONS: There are three: stenosis of the intra-cranial arteries, patent foramen ovale with atrial septum aneurysm and the basilar dolichoectasia trunks. NON-DEMONSTRATED SUPERIORITY: In atherosclerosis-induced cerebral ischemic accidents.

Publication types

  • Comparative Study
  • English Abstract
  • Review

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Antiphospholipid Syndrome / complications
  • Arteriosclerosis / complications
  • Aspirin / administration & dosage
  • Aspirin / therapeutic use
  • Atrial Fibrillation / complications
  • Cardiovascular Diseases / complications
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use
  • Heart Valve Prosthesis
  • Humans
  • Intracranial Arterial Diseases / complications
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use
  • Primary Prevention
  • Retrospective Studies
  • Risk
  • Risk Factors
  • Stroke / prevention & control*
  • Time Factors
  • Warfarin / administration & dosage
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Warfarin
  • Aspirin